Urinary Organic Acid (AKU) Test at Chughtai Lab

Introduction to Urinary Organic Acid (AKU) Testing at Chughtai Lab

The Urinary Organic Acid (AKU) test is a highly specialized, state-of-the-art biochemical genetics investigation designed to detect, diagnose, and monitor various inborn errors of metabolism (IEMs). Among these metabolic disorders, Alkaptonuria (AKU) is a primary target of this diagnostic profile. Alkaptonuria is a rare, inherited genetic condition characterized by the body’s inability to fully break down two amino acids: tyrosine and phenylalanine. This metabolic block is caused by a deficiency in the enzyme homogentisate 1,2-dioxygenase (HGD), leading to a systemic accumulation of homogentisic acid (HGA). Over time, the excretion of this acid in urine and its deposition in connective tissues cause severe clinical complications, including ochronosis (dark pigmentation of tissues) and early-onset destructive arthritis.

At Chughtai Lab, Pakistan’s leading diagnostic network, the Urinary Organic Acid analysis is performed using advanced Gas Chromatography-Mass Spectrometry (GC-MS) technology. This sophisticated analytical technique separates, identifies, and quantifies a vast spectrum of organic acids excreted in the urine. Beyond Alkaptonuria, this comprehensive metabolic profiling evaluates pathways related to amino acid, fatty acid, and carbohydrate metabolism, making it an indispensable tool in pediatric neurology, medical genetics, and metabolic medicine. By identifying specific abnormal metabolites, the test provides clinicians with a definitive biochemical signature, allowing for early intervention, dietary modification, and targeted therapeutic strategies that can prevent irreversible organ damage and developmental delays.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy of the Urinary Organic Acid (AKU) test at Chughtai Lab, strict adherence to patient preparation guidelines is essential. Because organic acid levels can be influenced by diet, medications, and physical state, patients and caregivers must follow these instructions carefully:

• Dietary Restrictions: Avoid consuming foods rich in vanilla, plums, bananas, tomatoes, and citrus fruits for at least 48 hours prior to sample collection, as these can introduce exogenous compounds that interfere with GC-MS analysis.
• Medication Management: Consult the referring physician regarding the temporary suspension of non-essential medications, particularly anticonvulsants, paracetamol, and certain antibiotics, which can produce confounding peaks on the chromatogram. Do not alter prescribed medication regimens without direct medical supervision.
• Hydration: Maintain normal, age-appropriate hydration. Excessive fluid intake can dilute the urine sample, potentially lowering the concentration of key organic acids below the analytical detection limit. Conversely, severe dehydration should be resolved before testing.
• Timing of Collection: For metabolic screening, a first-morning void is highly preferred because it represents the most concentrated sample of the day, maximizing the likelihood of detecting abnormal metabolites.
• Clinical Information: Provide the laboratory with a brief clinical history, including the patient’s age, current symptoms, diet (e.g., breastfed, formula-fed, or on a special metabolic diet), and any suspected genetic conditions.

During the Procedure

The process of obtaining a sample for the Urinary Organic Acid (AKU) test is non-invasive but requires meticulous collection and handling to prevent contamination and degradation of fragile organic compounds:

• Sample Collection: A random, clean-catch midstream urine sample (approximately 10 to 15 mL) should be collected in a sterile container provided by Chughtai Lab. For infants and young children who are not toilet trained, a pediatric urine collection bag must be used. Care must be taken to avoid contamination with stool, baby powder, or creams.
• Immediate Handling: Once collected, the urine sample must be delivered to the nearest Chughtai Lab collection center immediately. If a delay is unavoidable, the sample must be kept refrigerated (2 to 8 degrees Celsius) or frozen, depending on the specific transit time.
• Laboratory Processing: Upon arrival at the central reference laboratory, the sample undergoes preparation, which includes creatinine normalization to account for variations in urine concentration. The organic acids are then extracted, derivatized to make them volatile, and injected into the GC-MS system.
• Safety and Comfort: Because this is a urine-based test, there is no physical pain, discomfort, or risk of radiation associated with the procedure, making it entirely safe for neonates, infants, and pregnant patients.

When is a Urinary Organic Acid (AKU) Test Performed?

Suspected Alkaptonuria (AKU)

Physicians request this test when a patient presents with classic signs of Alkaptonuria. In infants, the most common early sign is urine that turns dark brown or black upon standing or when exposed to alkaline conditions (such as laundry detergents on diapers). In adults, the test is indicated when patients present with unexplained, progressive joint pain, particularly in the spine and large joints, accompanied by dark blue-black pigmentation of the sclera (white of the eye) or ear cartilage (ochronosis).

Unexplained Neonatal Metabolic Acidosis

In newborns, severe metabolic acidosis of unknown origin is a medical emergency. When a neonate exhibits an elevated anion gap, persistent metabolic acidosis, and ketonuria, clinicians order a urinary organic acid profile to rule out life-threatening organic acidemias such as Methylmalonic Acidemia, Propionic Acidemia, or Isovaleric Acidemia. Rapid diagnosis via this test allows for immediate dietary and therapeutic interventions to stabilize the infant.

Developmental Delay and Neurological Regression

Unexplained developmental delays, intellectual disabilities, progressive neurological regression, or intractable seizures in infants and young children are strong clinical indications for metabolic screening. Many inborn errors of metabolism present with progressive neurotoxicity due to the accumulation of toxic organic acids in the brain. Identifying these compounds helps pinpoint the underlying enzymatic defect.

Failure to Thrive in Infants

When an infant fails to gain weight or grow at a normal rate despite adequate caloric intake (failure to thrive), and this is accompanied by chronic vomiting, poor feeding, or muscular hypotonia, a urinary organic acid analysis is performed. This test helps identify underlying metabolic blocks that prevent the body from properly utilizing proteins, fats, or carbohydrates for energy and growth.

Recurrent Vomiting and Lethargy

Episodes of recurrent, unexplained vomiting, lethargy, or coma, especially when triggered by minor infections, fasting, or high-protein meals, suggest an intermittent metabolic decompensation. The Urinary Organic Acid test is crucial during these acute episodes, as it captures the transient excretion of abnormal metabolites that may not be present when the patient is clinically stable.

What Does a Urinary Organic Acid (AKU) Test Detect?

The Urinary Organic Acid (AKU) test at Chughtai Lab is capable of detecting a wide array of pathological metabolites. Clinically significant findings include:

• Homogentisic Acid (HGA): Highly elevated levels are diagnostic for Alkaptonuria (AKU).
• Methylmalonic Acid: Elevated levels indicate Methylmalonic Acidemia or Vitamin B12 deficiency.
• Propionic Acid / Propionylglycine: Markers for Propionic Acidemia.
• Isovalerylglycine / 3-Hydroxyisovaleric Acid: Elevated in Isovaleric Acidemia.
• Glutaric Acid: Elevated in Glutaric Aciduria Type 1.
• 3-Hydroxyglutaric Acid: A key diagnostic marker for Glutaric Aciduria Type 1.
• Methylcitric Acid: Elevated in propionyl-CoA carboxylase deficiency.
• Ethylmalonic Acid: Associated with Ethylmalonic Encephalopathy or short-chain acyl-CoA dehydrogenase deficiency.
• Adipic and Suberic Acids: Elevated in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency during fasting.
• Hexanoylglycine: A highly specific marker for MCAD deficiency.
• Lactic Acid: Elevated levels suggest mitochondrial disorders or tissue hypoxia.
• Pyruvic Acid: Elevated in pyruvate dehydrogenase deficiency or mitochondrial respiratory chain defects.
• 2-Ketoisocaproic Acid: Associated with Maple Syrup Urine Disease (MSUD).
• 2-Ketoisovaleric Acid: Also elevated in Maple Syrup Urine Disease.
• 4-Hydroxyphenylacetic Acid: Elevated in tyrosinemia and general tyrosine metabolic disorders.
• Succinylacetone: The pathognomonic marker for Tyrosinemia Type I.
• Orotic Acid: Elevated in urea cycle disorders, particularly Ornithine Transcarbamylase (OTC) deficiency.
• Urinary Glyceric Acid: Diagnostic marker for Hyperoxaluria Type II.
• Sebacic Acid: Elevated in dicarboxylic aciduria, indicating fatty acid oxidation defects.
• Fumaric Acid: Elevated in Fumarase deficiency, a severe mitochondrial encephalopathy.
• Malic Acid: Evaluated alongside fumaric acid to assess Krebs cycle integrity.
• 3-Methylglutaconic Acid: Marker for 3-Methylglutaconic Aciduria.
• Mevalonic Acid: Elevated in Mevalonic Aciduria (Mevalonate Kinase Deficiency).
• N-Acetylaspartic Acid (NAA): Highly elevated in Canavan disease.
• Vanillylmandelic Acid (VMA): Though primarily a catecholamine metabolite, abnormal levels can be detected during comprehensive organic acid profiling.

Turnaround Time and Report Access at Chughtai Lab

Because the Urinary Organic Acid (AKU) test involves complex Gas Chromatography-Mass Spectrometry (GC-MS) analysis, sample preparation, derivatization, and expert interpretation by qualified clinical biochemists and pathologists, the turnaround time is typically longer than routine blood tests. At Chughtai Lab, the results are generally available within 7 to 10 working days. Chughtai Lab prioritizes patient convenience by offering multiple ways to access reports. Patients can view and download their highly detailed, secure diagnostic reports online through the official Chughtai Lab website or the dedicated Chughtai Lab mobile application. Additionally, automated SMS notifications are sent to patients as soon as their reports are finalized, ensuring prompt access to critical medical data.

Urinary Organic Acid (AKU) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Homogentisic Acid (HGA)	Not detected or trace levels	Highly elevated (Diagnostic of Alkaptonuria)
Methylmalonic Acid (MMA)	Within age-specific reference range	Markedly elevated (Methylmalonic Acidemia)
Propionylglycine	Not detected	Elevated (Propionic Acidemia)
Isovalerylglycine	Not detected	Elevated (Isovaleric Acidemia)
Glutaric Acid	Trace to none	Significantly elevated (Glutaric Aciduria Type 1)
Lactic and Pyruvic Acids	Low, stable levels	Elevated (Mitochondrial disorders, hypoxia)
Branched-Chain Keto Acids	Not detected	Elevated (Maple Syrup Urine Disease)
Succinylacetone	Not detected	Detected (Tyrosinemia Type I)
Orotic Acid	Minimal excretion	Markedly elevated (Urea cycle defects)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Urinary Organic Acid (AKU) Testing?

• Experienced Healthcare Professionals: Chughtai Lab employs a team of highly qualified clinical pathologists, biochemists, and lab technologists specializing in metabolic and genetic testing.
• Patient-Focused Care: The laboratory ensures a seamless, compassionate, and supportive diagnostic journey for patients of all ages, especially infants and families dealing with rare genetic disorders.
• Quality Diagnostic Services: Operating with international quality standards, Chughtai Lab utilizes rigorous internal and external quality control protocols to guarantee accurate and reproducible results.
• Professional Reporting: Reports include comprehensive chromatograms and detailed clinical interpretations, helping physicians make informed diagnostic and therapeutic decisions.
• Modern Diagnostic Approach: Utilizing cutting-edge Gas Chromatography-Mass Spectrometry (GC-MS) technology ensures high sensitivity and specificity for complex organic acid profiling.
• Comfortable Environment: All Chughtai Lab collection centers across Pakistan are designed to provide a clean, hygienic, and welcoming environment for patients and their families.
• Convenient Location: With an extensive network of hundreds of collection centers across major cities in Pakistan, accessing specialized testing is highly convenient.
• Commitment to Accurate Diagnosis: Chughtai Lab is dedicated to delivering precise diagnostic insights that form the foundation of effective medical treatment and long-term disease management.